Do individual safety behaviour and felt safety responsibility promote safety performance? A case from a hospital from an offshore island region in Taiwan

被引:0
|
作者
Sung, Hun-Mei [1 ]
Chung, Kuo-Cheng [2 ]
Yen, Yu-Chin [3 ]
Su, Pi-Yu [4 ]
机构
[1] Triserv Gen Hosp, Penghu Branch, Dept Gen Ward, 90 Qianliao, Magong City 880026, Penghu Cty, Taiwan
[2] Natl Penghu Univ Sci & Technol, Dept Shipping & Transportat Management, 300 Liuhe Rd, Magong City 880011, Penghu Cty, Taiwan
[3] Triserv Gen Hosp, Penghu Branch, Dept Outpatient, 90 Qianliao, Magong City 880026, Penghu Cty, Taiwan
[4] Triserv Gen Hosp, Penghu Branch, Dept Gen Ward, 111 Sec 3,Xinglong Rd, Taipei City 116079, Taiwan
关键词
individual safety behaviour; felt safety responsibility; unsafe behaviour; safety compliance behaviour; safety performance; WORKPLACE SAFETY; CLIMATE; PREVENTION; MOTIVATION; LEADERSHIP; ACCIDENTS; HEALTH; IMPACT; ROLES; NORMS;
D O I
10.1504/IJHTM.2024.136541
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The global COVID-19 pandemic has strained healthcare systems due to uneven resource distribution. Healthcare workers face the dual challenge of treating patients while safeguarding themselves. Organisational reliability is vital. This study examines how safety compliance behaviours impact safety performance, focusing on individual safety behaviour and felt safety responsibility. Analysing data from 241 samples, using Smart PLS and SPSS, revealed key insights. Individual safety behaviour directly reduces unsafe acts and enhances safety compliance. Felt safety responsibility positively influences compliance. Unsafe behaviour detracts from safety performance; minimising it is crucial. Safety compliance enhances safety performance, suggesting a correlation between employee compliance and improved safety outcomes. The study has implications for theory and practice, providing insights for enhancing healthcare safety during pandemics.
引用
收藏
页码:31 / 48
页数:19
相关论文
共 50 条
  • [31] The Safety Profiles of Two First-Generation NTRK Inhibitors: Analysis of Individual Case Safety Reports from the FDA Adverse Event Reporting System (FAERS) Database
    Liguori, Valerio
    Gaio, Mario
    Zinzi, Alessia
    Cagnotta, Cecilia
    Riccardi, Consiglia
    Docimo, Giovanni
    Capuano, Annalisa
    BIOMEDICINES, 2023, 11 (09)
  • [32] Do Leveraged Firms Underinvest in Corporate Social Responsibility? Evidence from Health and Safety Programs in U.S. Firms
    Christophe Moussu
    Steve Ohana
    Journal of Business Ethics, 2016, 135 : 715 - 729
  • [33] Breast cancer patterns and the related drugs' safety from Taipei City Hospital and the National Adverse Drug Reaction Database in Taiwan
    Huang, R. Y. W.
    Chang, W. P.
    Liao, C. C.
    DRUG SAFETY, 2006, 29 (10) : 929 - 929
  • [34] Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports: A Note of Caution Response
    Williams, Benjamin
    Lee, Kenn
    Ewah, Silas Okey
    Neelam, Kishen
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2024, 44 (04) : 445 - 445
  • [35] Adverse drug reactions of statins in a paediatric population: A descriptive analysis of individual case safety reports from Vigibase
    Conte, Cecile
    Vert, Charlotte
    Rousseau, Vanessa
    Chebane, Leyla
    Montastruc, Jean Louis
    Durrieu, Genevieve
    Olivier, Pascale
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 391 - 391
  • [36] Cannabinoid-related acute pancreatitis. An update from international literature and individual case safety reports
    Azam, C.
    Buscail, L.
    Culetto, A.
    Lapeyre-Mestre, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2021, 35 : 112 - 112
  • [37] Adverse drug reactions of statins in a paediatric population: a descriptive analysis of individual case safety reports from VigiBase®
    Vert, C.
    Conte, C.
    Rousseau, V.
    Chebane, L.
    Montastruc, J. L.
    Durrieu, G.
    Olivier, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 67 - 67
  • [38] Surviving relatives as stakeholders for corporate social responsibility and as leaders for meaningful safety improvement. A case study from the Netherlands
    Zwetsloot, Gerard I. J. M.
    de Bruin, Theo
    SAFETY SCIENCE, 2023, 157
  • [39] Safety profile of Dupilumab during pregnancy: a data mining and disproportionality analysis of over 37,000 reports from the WHO individual case safety reporting database (VigiBase™)
    Khamisy-Farah, R.
    Damiani, G.
    Kong, J. D.
    Wu, J.
    Bragazzi, N. L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (17) : 5448 - 5451
  • [40] Adverse Drug Reactions Reported With Cholinesterase Inhibitors: An Analysis of 16 Years of Individual Case Safety Reports From VigiBase
    Kroeger, Edeltraut
    Mouls, Marie
    Wilchesky, Machelle
    Berkers, Mieke
    Carmichael, Pierre-Hugues
    van Marum, Rob
    Souverein, Patrick
    Egberts, Toine
    Laroche, Marie-Laure
    ANNALS OF PHARMACOTHERAPY, 2015, 49 (11) : 1197 - 1206